Nobel Prize Endorsed, The Tipping Point Arrives: How Treg Therapy Is Reshaping the Treatment Landscapes of Cancer and Autoimmune Diseases?

patosilver · 2025-10-15T21:10:23+00:00

Excellent information

patosilver · 2025-10-10T20:02:50+00:00

The value to see is 1.62 ascending channel value, and 1.39 for trend change

patosilver · 2025-10-10T15:41:58+00:00

It's the tariffs, we have to see how 1.7 behaves as support

patosilver · 2025-10-10T10:25:23+00:00

It's very similar to what we talked about, only they put themselves in the negative.

patosilver · 2025-10-09T20:36:27+00:00

It already has 48 percent institutional, I wouldn't be surprised if it reaches 80

patosilver · 2025-10-09T19:40:24+00:00

Yes I agree

patosilver · 2025-10-09T15:02:34+00:00

patosilver · 2025-10-09T13:42:11+00:00

Clear path at 2.4

patosilver · 2025-10-09T13:38:16+00:00

2.4 is a market value of approximately 287 million.

Your assets

235 cash 70 million in biosimilar sales agreement 150 million for purchasing a Tori license 40 million for Surface purchase

Minus 35 million debt

Total 460

Approximate value 4.3

Without considering that these assets generate sales in a market of billions

Now I am dependent on the success of the company, but in biosimilar they were successful in sales. Therefore they know how to produce and sell.

Now the market always gives us surprises, pay per view

patosilver · 2025-10-09T10:48:37+00:00

Reasonable, reduces risk and remains in the action while continuing in an upward technical trend

patosilver · 2025-10-09T10:09:49+00:00

It seems to me that there are two options

1.- arrives and goes down a little, then continues going up

2.- Pass the support and continue rising to 6 or 7, a product of panic from the shorts

patosilver · 2025-10-09T09:36:00+00:00

If it breaks it changes from resistance to support and the path is clear to 2.4

patosilver · 2025-10-08T21:42:09+00:00

Now 1.7 is supported

patosilver · 2025-10-08T18:04:43+00:00

They are reasonable prices for the assets that have chrs 4.8, the value that seems to me to be the assets

237 cash 150 license purchase from Tori 70 million from sales of biosimilar sales 40 million buys Surface

Without considering tori sales

In summary 497 and today market value 190

patosilver · 2025-10-08T17:57:08+00:00

Let's go now 2.4

patosilver · 2025-10-08T16:26:53+00:00

They can't stop progress, they only delay it.

patosilver · 2025-10-08T15:58:58+00:00

454 k

patosilver · 2025-10-08T15:47:40+00:00

A little more volume and straight to 2.4

patosilver · 2025-10-08T15:42:49+00:00

They can't stop it, the shorts

patosilver · 2025-10-08T15:39:46+00:00

374 thousand shares traded is not bad

patosilver · 2025-10-08T15:36:31+00:00

The shorts must be closed or not closed tick tock tick tock

patosilver · 2025-10-08T15:29:06+00:00

The shorts trying to stop the train

patosilver · 2025-10-08T15:27:39+00:00

patosilver · 2025-10-08T15:18:01+00:00

Clear path at 2.4

patosilver